(19)
(11) EP 4 041 768 A1

(12)

(43) Date of publication:
17.08.2022 Bulletin 2022/33

(21) Application number: 20803343.1

(22) Date of filing: 09.10.2020
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
 A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2803; C07K 2317/24; C07K 2317/33; C07K 2317/34; C07K 2317/92; A61P 35/00
(86) International application number:
PCT/US2020/055090
(87) International publication number:
WO 2021/072277 (15.04.2021 Gazette 2021/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.10.2019 US 201962912867 P

(71) Applicant: StCube & Co.
Seoul 06164 (KR)

(72) Inventor:
  • YOO, Stephen S.
    Centerville, VA 20120 (US)

(74) Representative: Appleyard Lees IP LLP 
15 Clare Road
Halifax HX1 2HY
Halifax HX1 2HY (GB)

   


(54) ANTIBODIES SPECIFIC TO GLYCOSYLATED LAG3 AND METHODS OF USE THEREOF